Al-Jabi Samah W, Zyoud Sa'ed H, Sweileh Waleed M, Wildali Aysha H, Saleem Hanan M, Aysa Hayat A, Badwan Mohammad A, Awang Rahmat
Department of Clinical and Community, Pharmacy College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
Health Expect. 2015 Dec;18(6):3336-48. doi: 10.1111/hex.12324. Epub 2014 Dec 7.
Evaluation of the association between treatment satisfaction and health-related quality of life (HRQoL) may enable health-care providers to understand the issues that influence quality of life and to recognize the aspects of hypertension treatment that need improvement to enhance the long-term treatment outcomes.
The aim of this study was to determine the relationship between HRQoL and treatment satisfaction in a sample of Palestinian hypertensive patients.
A cross-sectional study was conducted, adopting the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4) for the assessment of treatment satisfaction and using the European Quality of Life scale (EQ-5D-5L) for the assessment of HRQoL. Descriptive and comparative statistics were used to describe socio-demographic and disease-related characteristics of the patients. All analyses were performed using SPSS v 15.0.
Four hundred and ten hypertensive patients were enrolled in the study. This study findings indicate a positive correlation between all satisfaction domains and HRQoL. Significant differences were observed between this study variables (P < 0.001). After adjustment for covariates using multiple linear regression, an increase of one point in the global satisfaction scale was associated with a 0.16 increase in EQ-5D index scores (r = 0.16; P < 0.001).
Patients with reportedly higher satisfaction scores have reported relatively higher EQ-5D-5L index values. These study findings could be helpful in clinical practice, mainly in the early treatment of hypertensive patients, at a point where improving treatment satisfaction and HRQoL is still possible.
评估治疗满意度与健康相关生活质量（HRQoL）之间的关联，可能有助于医疗保健提供者了解影响生活质量的问题，并认识到高血压治疗中需要改进的方面，以提高长期治疗效果。
本研究旨在确定巴勒斯坦高血压患者样本中HRQoL与治疗满意度之间的关系。
进行了一项横断面研究，采用药物治疗满意度问卷（TSQM 1.4）评估治疗满意度，并使用欧洲生活质量量表（EQ-5D-5L）评估HRQoL。描述性和比较性统计用于描述患者的社会人口统计学和疾病相关特征。所有分析均使用SPSS v 15.0进行。
410名高血压患者纳入本研究。本研究结果表明，所有满意度领域与HRQoL之间存在正相关。本研究变量之间观察到显著差异（P < 0.001）。使用多元线性回归对协变量进行调整后，全球满意度量表上增加1分与EQ-5D指数得分增加0.16相关（r = 0.16；P < 0.001）。
据报道，满意度得分较高的患者EQ-5D-5L指数值相对较高。这些研究结果可能有助于临床实践，主要是在高血压患者的早期治疗中，此时提高治疗满意度和HRQoL仍然是可能的。
